Tobacco/nicotine use | ||||
---|---|---|---|---|
Former user | Current user | |||
Adjusted OR (95% CI)a | p-value | Adjusted OR (95% CI)a | p-value | |
Age (increasing) | 1.05 (1.01–1.08) | 0.005 | 1.00 (0.99–1.02) | 0.614 |
Gender (male) | 36.75 (16.28–82.93) | < 0.001 | 72.12 (45.23–114.99) | < 0.001 |
Residence (Cairo) | 1.29 (0.62–2.68) | 0.493 | 1.26 (0.90–1.76) | 0.174 |
Area (Urban) | 1.10 (0.47–2.58) | 0.832 | 0.91 (0.62–1.33) | 0.619 |
Marital status (married) | 0.71 (0.39–1.27) | 0.246 | 1.08 (0.81–1.44) | 0.596 |
Education (lower) | 1.23 (0.83–1.83) | 0.296 | 1.42 (1.17–1.71) | < 0.001 |
Occupation (nurse)b | 1.21 (0.61–2.40) | 0.596 | 2.81 (2.01–3.92) | < 0.001 |
Occupation (non-clinical)b | 1.29 (0.59–2.82) | 0.529 | 3.21 (2.21–4.67) | < 0.001 |
Pre-existing medical condition (yes) | 1.87 (1.05–3.33) | 0.033 | 1.22 (0.86–1.74) | 0.271 |
Symptoms (yes) | 1.76 (1.07–2.90) | 0.027 | 1.07 (0.82–1.40) | 0.619 |
SARS-Co-V2 test result (positive) | 0.74 (0.26–2.09) | 0.575 | 0.68 (0.41–1.13) | 0.136 |